Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Non Muscle Invasive Bladder Cancer Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Celgene Corporation
Heat Biologics, Inc
Astellas Pharma Inc
APIM Therapeutics AS
Viralytics Ltd
Altor BioScience Corporation
Vakzine Projekt Management GmbH
Viventia Bio Inc
UroGen Pharmaceuticals, Ltd
Bavarian Nordic A/S
Taris Biomedical LLC
Telesta Therapeutics Inc
BioCancell Ltd
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Non Muscle Invasive Bladder Cancer Drugs Market Overview 2018-2029
-
1.1 China Non Muscle Invasive Bladder Cancer Drugs Industry Development Overview
-
1.2 China Non Muscle Invasive Bladder Cancer Drugs Industry Development History
-
1.3 China Non Muscle Invasive Bladder Cancer Drugs Industry Market Size (2018-2029)
-
1.4 China Non Muscle Invasive Bladder Cancer Drugs Market Analysis by Type from Production Side
-
1.4.1 China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Non Muscle Invasive Bladder Cancer Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Non Muscle Invasive Bladder Cancer Drugs Market Analysis by Region
-
1.6.1 North China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Non Muscle Invasive Bladder Cancer Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Non Muscle Invasive Bladder Cancer Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Non Muscle Invasive Bladder Cancer Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Non Muscle Invasive Bladder Cancer Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Non Muscle Invasive Bladder Cancer Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Non Muscle Invasive Bladder Cancer Drugs Industry Development
Chapter 3 Non Muscle Invasive Bladder Cancer DrugsIndustry Chain Analysis
-
3.1 Non Muscle Invasive Bladder Cancer Drugs Industry Chain
-
3.2 Non Muscle Invasive Bladder Cancer Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Non Muscle Invasive Bladder Cancer Drugs Market
-
3.3 Non Muscle Invasive Bladder Cancer Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Non Muscle Invasive Bladder Cancer Drugs Market
Chapter 4 China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
4.1 China Non Muscle Invasive Bladder Cancer Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Non Muscle Invasive Bladder Cancer Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 1
-
4.5.2 China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 2
-
4.5.3 China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 3
Chapter 5 China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Non Muscle Invasive Bladder Cancer Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 1
-
5.5.2 China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 2
-
5.5.3 China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 3
Chapter 6 China Non Muscle Invasive Bladder Cancer Drugs Market, by Region
-
6.1 China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Production Value, by Region
-
6.2 China Non Muscle Invasive Bladder Cancer Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
7.1 North China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
7.2 North China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 8 Central China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
8.1 Central China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
8.2 Central China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 9 South China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
9.1 South China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
9.2 South China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 10 East China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
10.1 East China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
10.2 East China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 11 Northeast China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
11.1 Northeast China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
11.2 Northeast China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 12 Southwest China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
12.1 Southwest China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
12.2 Southwest China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 13 Northwest China Non Muscle Invasive Bladder Cancer Drugs Market Analysis
-
13.1 Northwest China Non Muscle Invasive Bladder Cancer Drugs Market, by Type
-
13.2 Northwest China Non Muscle Invasive Bladder Cancer Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Celgene Corporation
-
14.1.1 Celgene Corporation Company Profile
-
14.1.2 Celgene Corporation Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Heat Biologics, Inc
-
14.2.1 Heat Biologics, Inc Company Profile
-
14.2.2 Heat Biologics, Inc Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Astellas Pharma Inc
-
14.3.1 Astellas Pharma Inc Company Profile
-
14.3.2 Astellas Pharma Inc Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 APIM Therapeutics AS
-
14.4.1 APIM Therapeutics AS Company Profile
-
14.4.2 APIM Therapeutics AS Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Viralytics Ltd
-
14.5.1 Viralytics Ltd Company Profile
-
14.5.2 Viralytics Ltd Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Altor BioScience Corporation
-
14.6.1 Altor BioScience Corporation Company Profile
-
14.6.2 Altor BioScience Corporation Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Vakzine Projekt Management GmbH
-
14.7.1 Vakzine Projekt Management GmbH Company Profile
-
14.7.2 Vakzine Projekt Management GmbH Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Viventia Bio Inc
-
14.8.1 Viventia Bio Inc Company Profile
-
14.8.2 Viventia Bio Inc Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 UroGen Pharmaceuticals, Ltd
-
14.9.1 UroGen Pharmaceuticals, Ltd Company Profile
-
14.9.2 UroGen Pharmaceuticals, Ltd Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bavarian Nordic A/S
-
14.10.1 Bavarian Nordic A/S Company Profile
-
14.10.2 Bavarian Nordic A/S Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Taris Biomedical LLC
-
14.11.1 Taris Biomedical LLC Company Profile
-
14.11.2 Taris Biomedical LLC Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Telesta Therapeutics Inc
-
14.12.1 Telesta Therapeutics Inc Company Profile
-
14.12.2 Telesta Therapeutics Inc Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 BioCancell Ltd
-
14.13.1 BioCancell Ltd Company Profile
-
14.13.2 BioCancell Ltd Non Muscle Invasive Bladder Cancer Drugs Market Performance
-
14.13.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Non Muscle Invasive Bladder Cancer Drugs Industry Research Conclusions
-
15.2 Non Muscle Invasive Bladder Cancer Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Industry Market Size (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate from 2018-2029
-
Figure Non Muscle Invasive Bladder Cancer Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Share by Type in 2018
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Share by Type in 2023
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Share by Application in 2018
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Share by Application in 2023
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Region (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Production Value by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Production Value Share by Region (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Production Value Share by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Sales Value by Region (2018-2023)
-
Table China Non Muscle Invasive Bladder Cancer Drugs Sales Value Share by Region (2018-2023)
-
Figure China Non Muscle Invasive Bladder Cancer Drugs Sales Value Share by Region (2018-2023)
-
Table North China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table North China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table North China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table North China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table Central China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Central China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table South China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table South China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table South China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table East China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table East China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table East China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Non Muscle Invasive Bladder Cancer Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Non Muscle Invasive Bladder Cancer Drugs Sales Volume Share by Application (2018-2023)
-
Table Celgene Corporation Company Profile
-
Table Celgene Corporation Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Heat Biologics, Inc Company Profile
-
Table Heat Biologics, Inc Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Astellas Pharma Inc Company Profile
-
Table Astellas Pharma Inc Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table APIM Therapeutics AS Company Profile
-
Table APIM Therapeutics AS Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Viralytics Ltd Company Profile
-
Table Viralytics Ltd Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Altor BioScience Corporation Company Profile
-
Table Altor BioScience Corporation Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Vakzine Projekt Management GmbH Company Profile
-
Table Vakzine Projekt Management GmbH Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Viventia Bio Inc Company Profile
-
Table Viventia Bio Inc Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table UroGen Pharmaceuticals, Ltd Company Profile
-
Table UroGen Pharmaceuticals, Ltd Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Bavarian Nordic A/S Company Profile
-
Table Bavarian Nordic A/S Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Taris Biomedical LLC Company Profile
-
Table Taris Biomedical LLC Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table Telesta Therapeutics Inc Company Profile
-
Table Telesta Therapeutics Inc Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
Table BioCancell Ltd Company Profile
-
Table BioCancell Ltd Non Muscle Invasive Bladder Cancer Drugs Revenue, Price and Gross (2018-2023)
-
